FDA Inspection 1117682 — Daito Pharmaceutical Co., Ltd.
The FDA completed an inspection of Daito Pharmaceutical Co., Ltd. on Jan 31, 2020 in Toyama. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jan 31, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Toyama (Japan)